The settlement brings the total amount of money recovered by the state from the lawsuit to $678 million, closing a case that began in 2005 with more than four dozen drugmakers.
The lawsuit alleges the involved drugmakers took advantage of state Medicaid programs’ reliance on average wholesale prices when setting reimbursement levels.
GlaxoSmithKline will pay the largest chunk of the settlement, contributing $54.6 million, followed by Johnson & Johnson, which will pay$49.5 million. Pfizer will contribute $41 million.
The other drugmakers included in the settlement are Abbott, Aventis, Aventis Behring, B. Braun Medical, Forest Laboratories, Janssen Pharmaceutical Products , McNeil-PPC, Ortho Biotech Products, Ortho-McNeil Pharmaceutical, Novartis, Pharmacia and TAP Pharmaceutical Products.
The drugmakers did not admit liability.
More articles on pharmacy:
Novant Health leaders talk Walgreens partnership goals for 2020
Sanofi recalls heartburn drug over cancer risks
Centura Health opens retail pharmacy
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
